GeneMetrics unveils a customizable genomics platform unifying lifestyle, clinical & diagnostic testing. Go beyond white-label with auditable science, full data GeneMetrics unveils a customizable genomics platform unifying lifestyle, clinical & diagnostic testing. Go beyond white-label with auditable science, full data

GeneMetrics Platform Addresses Fragmented Genetics Market with Fully Customizable Testing Solutions

3 min read

The genetics marketplace presents health companies, practitioners, and researchers with a difficult choice between consumer-friendly kits lacking clinical depth and inflexible, overly technical clinical platforms. This fragmentation forces clients to assemble incomplete solutions from multiple providers, leading to disjointed patient experiences characterized by multiple tests, portals, and confusing reports. GeneMetrics was developed to resolve this industry-wide challenge by providing the first platform to unify lifestyle, clinical, diagnostic, and advanced genetic testing in one location.

Unlike typical white-label solutions that offer generic, one-size-fits-all models, GeneMetrics functions as a custom testing product development company where every aspect—from kit design and packaging to wet-lab testing and data reporting—can be tailored to a client’s specific vision, brand identity, and clinical philosophy. The platform’s fundamental promise is limitless customization, supported by one of the largest libraries of report elements and scientific topics, featuring thousands of validated options. Clients can create offerings ranging from simple to highly advanced, integrating genetics, bloodwork, and lifestyle factors into single, cohesive patient reports.

GeneMetrics provides extensive sequencing and laboratory technology options, including bead-chip genotyping arrays, clinical-grade Whole Exome Sequencing (WES), clinical-grade Whole Genome Sequencing (WGS), PCR and PGx panels, and testing for epigenetics, blood, urine, saliva, and microbiomes. This guarantees flexibility across consumer lifestyle kits, clinical diagnostics, and enterprise research. The platform also features a fully customizable recommendation engine that prioritizes clarity over quantity, generating actionable steps for supplements, diet, lifestyle modifications, or medications to improve patient outcomes and practitioner efficiency.

Scientific integrity is paramount, with every methodology thoroughly validated and fully auditable. The platform includes a dedicated auditing system, making it a transparent solution, and incorporates machine learning algorithms referencing over 140,000 peer-reviewed studies. GeneMetrics adheres to high compliance standards including HIPAA, GDPR, SOC 2 Type 2, and ISO27001, with data protected through multi-layer encryption. Clients maintain 100 percent ownership of their data, with many opting to transfer ownership directly to patients. For transparency, GeneMetrics provides live compliance policies and monitoring at https://trust.genemetrics.com.

The platform is engineered for rapid scalability, supporting turn-key logistics management from boutique clinics to large-scale genomics initiatives. While confidentiality agreements prevent disclosing client names, GeneMetrics is a trusted backend provider for leading genomics and health companies globally. By merging genetics, epigenetics, blood, microbiome, and lifestyle data into one cohesive ecosystem, the company is facilitating a transition from reactive medicine to personalized, preventive care. More information about the company is available at https://genemetrics.com.

Blockchain Registration, Verification & Enhancement provided by NewsRamp™

This news story relied on content distributed by Press Services. Blockchain Registration, Verification & Enhancement provided by NewsRamp™. The source URL for this press release is GeneMetrics Platform Addresses Fragmented Genetics Market with Fully Customizable Testing Solutions.

The post GeneMetrics Platform Addresses Fragmented Genetics Market with Fully Customizable Testing Solutions appeared first on citybuzz.

Disclaimer: The articles reposted on this site are sourced from public platforms and are provided for informational purposes only. They do not necessarily reflect the views of MEXC. All rights remain with the original authors. If you believe any content infringes on third-party rights, please contact service@support.mexc.com for removal. MEXC makes no guarantees regarding the accuracy, completeness, or timeliness of the content and is not responsible for any actions taken based on the information provided. The content does not constitute financial, legal, or other professional advice, nor should it be considered a recommendation or endorsement by MEXC.

You May Also Like

Shocking OpenVPP Partnership Claim Draws Urgent Scrutiny

Shocking OpenVPP Partnership Claim Draws Urgent Scrutiny

The post Shocking OpenVPP Partnership Claim Draws Urgent Scrutiny appeared on BitcoinEthereumNews.com. The cryptocurrency world is buzzing with a recent controversy surrounding a bold OpenVPP partnership claim. This week, OpenVPP (OVPP) announced what it presented as a significant collaboration with the U.S. government in the innovative field of energy tokenization. However, this claim quickly drew the sharp eye of on-chain analyst ZachXBT, who highlighted a swift and official rebuttal that has sent ripples through the digital asset community. What Sparked the OpenVPP Partnership Claim Controversy? The core of the issue revolves around OpenVPP’s assertion of a U.S. government partnership. This kind of collaboration would typically be a monumental endorsement for any private cryptocurrency project, especially given the current regulatory climate. Such a partnership could signify a new era of mainstream adoption and legitimacy for energy tokenization initiatives. OpenVPP initially claimed cooperation with the U.S. government. This alleged partnership was said to be in the domain of energy tokenization. The announcement generated considerable interest and discussion online. ZachXBT, known for his diligent on-chain investigations, was quick to flag the development. He brought attention to the fact that U.S. Securities and Exchange Commission (SEC) Commissioner Hester Peirce had directly addressed the OpenVPP partnership claim. Her response, delivered within hours, was unequivocal and starkly contradicted OpenVPP’s narrative. How Did Regulatory Authorities Respond to the OpenVPP Partnership Claim? Commissioner Hester Peirce’s statement was a crucial turning point in this unfolding story. She clearly stated that the SEC, as an agency, does not engage in partnerships with private cryptocurrency projects. This response effectively dismantled the credibility of OpenVPP’s initial announcement regarding their supposed government collaboration. Peirce’s swift clarification underscores a fundamental principle of regulatory bodies: maintaining impartiality and avoiding endorsements of private entities. Her statement serves as a vital reminder to the crypto community about the official stance of government agencies concerning private ventures. Moreover, ZachXBT’s analysis…
Share
BitcoinEthereumNews2025/09/18 02:13
United States Building Permits Change dipped from previous -2.8% to -3.7% in August

United States Building Permits Change dipped from previous -2.8% to -3.7% in August

The post United States Building Permits Change dipped from previous -2.8% to -3.7% in August appeared on BitcoinEthereumNews.com. Information on these pages contains forward-looking statements that involve risks and uncertainties. Markets and instruments profiled on this page are for informational purposes only and should not in any way come across as a recommendation to buy or sell in these assets. You should do your own thorough research before making any investment decisions. FXStreet does not in any way guarantee that this information is free from mistakes, errors, or material misstatements. It also does not guarantee that this information is of a timely nature. Investing in Open Markets involves a great deal of risk, including the loss of all or a portion of your investment, as well as emotional distress. All risks, losses and costs associated with investing, including total loss of principal, are your responsibility. The views and opinions expressed in this article are those of the authors and do not necessarily reflect the official policy or position of FXStreet nor its advertisers. The author will not be held responsible for information that is found at the end of links posted on this page. If not otherwise explicitly mentioned in the body of the article, at the time of writing, the author has no position in any stock mentioned in this article and no business relationship with any company mentioned. The author has not received compensation for writing this article, other than from FXStreet. FXStreet and the author do not provide personalized recommendations. The author makes no representations as to the accuracy, completeness, or suitability of this information. FXStreet and the author will not be liable for any errors, omissions or any losses, injuries or damages arising from this information and its display or use. Errors and omissions excepted. The author and FXStreet are not registered investment advisors and nothing in this article is intended…
Share
BitcoinEthereumNews2025/09/18 02:20
CME Group to launch Solana and XRP futures options in October

CME Group to launch Solana and XRP futures options in October

The post CME Group to launch Solana and XRP futures options in October appeared on BitcoinEthereumNews.com. CME Group is preparing to launch options on SOL and XRP futures next month, giving traders new ways to manage exposure to the two assets.  The contracts are set to go live on October 13, pending regulatory approval, and will come in both standard and micro sizes with expiries offered daily, monthly and quarterly. The new listings mark a major step for CME, which first brought bitcoin futures to market in 2017 and added ether contracts in 2021. Solana and XRP futures have quickly gained traction since their debut earlier this year. CME says more than 540,000 Solana contracts (worth about $22.3 billion), and 370,000 XRP contracts (worth $16.2 billion), have already been traded. Both products hit record trading activity and open interest in August. Market makers including Cumberland and FalconX plan to support the new contracts, arguing that institutional investors want hedging tools beyond bitcoin and ether. CME’s move also highlights the growing demand for regulated ways to access a broader set of digital assets. The launch, which still needs the green light from regulators, follows the end of XRP’s years-long legal fight with the US Securities and Exchange Commission. A federal court ruling in 2023 found that institutional sales of XRP violated securities laws, but programmatic exchange sales did not. The case officially closed in August 2025 after Ripple agreed to pay a $125 million fine, removing one of the biggest uncertainties hanging over the token. This is a developing story. This article was generated with the assistance of AI and reviewed by editor Jeffrey Albus before publication. Get the news in your inbox. Explore Blockworks newsletters: Source: https://blockworks.co/news/cme-group-solana-xrp-futures
Share
BitcoinEthereumNews2025/09/17 23:55